Home › Funds › AIHC Capital Management Ltd › ORIC
AIHC Capital Management Ltd position in ORIC
ORIC PHARMACEUTICALS INC · Health Care
AIHC Capital Management Ltd reported holding 4,630,986 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$62.4M, representing 57.39% of its reported portfolio and ranking #1 among its reported holdings. AIHC Capital Management Ltd has disclosed ORIC holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How AIHC Capital Management Ltd's ORIC position evolved
AIHC Capital Management Ltd first disclosed a stake in ORIC in Q1 2026 at 2,459,551 shares (US$31.2M). The position peaked in Q3 2026 at 4,630,986 shares, worth US$62.4M. Across 3 filings, AIHC Capital Management Ltd increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 4,630,986 shares valued at US$62.4M — an increase of 802,526 shares quarter over quarter.. Notable position changes include a 56% increase in Q2 2026 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.46M | $31.16M | New |
| Q2 2026 | 3.83M | $41.46M | Add |
| Q3 2026 | 4.63M | $62.38M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ORIC and 13F data
ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 42 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M), Venrock Adviser, LLC (US$46.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ORIC
- Nextech Invest Ltd. 7.16M sh · $77.57M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.62M sh · $49.98M · Q2 2026
- Venrock Adviser, LLC 4.32M sh · $46.78M · Q2 2026
- Siren, L.L.C. 3.36M sh · $45.23M · Q3 2026
- NEA Management Company, LLC 4.12M sh · $44.60M · Q2 2026
- EcoR1 Capital, LLC 3.03M sh · $40.79M · Q3 2026
- Column Group LLC 3.54M sh · $38.35M · Q2 2026
- First Turn Management, LLC 1.57M sh · $21.21M · Q3 2026
- MPM BioImpact LLC 1.88M sh · $20.38M · Q2 2026
- Paradigm Biocapital Advisors LP 1.51M sh · $20.28M · Q3 2026
- Integral Health Asset Management, LLC 1.70M sh · $20.20M · Q3 2026
- Vivo Capital, LLC 924.39K sh · $12.45M · Q3 2026
More on AIHC Capital Management Ltd
FAQ
How long has AIHC Capital Management Ltd held ORIC?
AIHC Capital Management Ltd has disclosed ORIC holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is AIHC Capital Management Ltd's current position in ORIC?
As of Q3 2026, AIHC Capital Management Ltd holds 4.63M shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $62.38M, representing 57.39% of its reported portfolio and ranking #1.
Has AIHC Capital Management Ltd been buying or selling ORIC?
In the latest 13F filing (Q3 2026), AIHC Capital Management Ltd increased its position in ORIC. The position peaked in Q3 2026 at 4.63M shares.
Which other funds hold ORIC?
Other major institutional holders of ORIC include Nextech Invest Ltd., SR ONE CAPITAL MANAGEMENT, LP, Venrock Adviser, LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.